Biolegend, 640930, APC Annexin V Apoptosis Detection Kit with 7-AAD
100tests
Catalog Number: 640930
Send an RFQ.
Category
| Verified Reactivity | Human, Mouse, Rat |
|---|---|
| Reported Reactivity | Other Species |
| Concentration | Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.) |
| Storage & Handling | Store between 2°C and 8°C. Do not freeze. Caution: 7-AAD is a potential carcinogen. It is recommended that the user wear protective clothing, gloves, and eye/face protection in order to avoid contact with skin and eyes. |
| Application | FC - Quality tested |
| Excitation Laser | Red Laser (633 nm) |
| Application Notes | Annexin V Staining Wash cells twice with cold BioLegend Cell Staining Buffer (Cat. No. 420201) and then resuspend the desired amount of cells in Annexin V Binding Buffer (Cat. No. 422201) at a concentration of 0.25-1.0 x 107 cells/mL Transfer 100 µL of cell suspension in 5 mL test tube. Add 5 µL of fluorochrome conjugated Annexin V. Stain with a viability dye, such as PI (Cat. No. 421301), 7-AAD (Cat. Nos. 420403 & 420404), or Helix NP dyes (Cat. Nos. 425301, 425303, & 425305), if desired. Gently vortex the cells and incubate for 15 min at RT (25°C) in the dark. Add 400* µL of Annexin V Binding Buffer (Cat. No. 422201) to each tube. *For more concentrated samples, add a minimum of 200 µl of Annexin V Binding Buffer in this step. Analyze by flow cytometry. For a better experience detecting apoptosis, we now recommend Apotracker™. Cell staining with Apotracker™ is Calcium independent. Thus, no special buffers are required, and the protocol can be shortened for single-step co-staining with other reagents. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application References(PubMed link indicates BioLegend citation) | Maciel E, et al. 2014. Arch Biochem Biophys. 548:38. PubMed |
|---|
| Product Citations | Cook ME, et al. 2022. Sci Immunol. 7:eabo0981. PubMed Lamamy J, et al. 2022. Front Immunol. 13:1054425. PubMed Nakamura H, et al. 2023. PLoS One. 18:e0282227. PubMed Shi P, et al. 2023. Commun Biol. 6:334. PubMed Huang F, et al. 2023. Int J Mol Sci. 24:. PubMed Saez-Ayala M, et al. 2023. Nat Commun. 14:3079. PubMed Balood M, et al. 2022. Nature. 611:405. PubMed Català C, et al. 2022. iScience. 25:105078. PubMed Chiarella E, et al. 2020. Heliyon. 6:e04020. PubMed Chen CC, et al. 2020. Cancer Cell. 37:71. PubMed Paz H, et al. 2018. J Exp Clin Cancer Res. 37:67. PubMed Rutherford TR, et al. 2021. Cell Death Dis. 12:872. PubMed Fluckiger A, et al. 2016. Oncogene. 10.1038/onc.2015.523. PubMed Krone A, et al. 2022. Sci Rep. 218:. PubMed Papadas A, et al. 2022. Cell Rep. 40:111201. PubMed Cribioli E, et al. 2022. Front Immunol. 13:976628. PubMed Huangfu J, et al. 2021. Cell Death Dis. 12:386. PubMed Li W, et al. 2022. PeerJ. 10:e14086. PubMed Gómez-Aleza C, et al. 2020. Nat Commun. 4.857638889. PubMed Broggi A, et al. 2017. Nat Immunol. 18:1084. PubMed Wu L, et al. 2022. Theranostics. 12:842. PubMed Yao F, et al. 2021. Nat Commun. 12:7333. PubMed Lee A, et al. 2022. Int J Oncol. 60:. PubMed Chen X, et al. 2021. Theranostics. 11:3392. PubMed Xie J, et al. 2018. Oncol Lett. 16:157. PubMed Vogiatzi F, et al. 2022. Blood Adv. 6:4847. PubMed Dong Y, et al. 2020. J Leukoc Biol. 108:1711. PubMed Li H,et al. 2017. Sci Rep.. 10.1038/s41598-017-13471-4. PubMed Zhuo J, et al. 2021. Cell Death Dis. 12:1084. PubMed Wu H, et al. 2021. Cell Death Discov. 7:225. PubMed Lei J, et al. 2021. Theranostics. 4251:11. PubMed Tanaka T, et al. 2020. Sci Rep. 10:15169. PubMed Dolan M, et al. 2019. PLoS One. 14:e0220101. PubMed Tang Q, et al. 2021. Genes Dev. 35:528. PubMed Gong H, et al. 2019. EBioMedicine. 44:138. PubMed Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed Singh SK, et al. 2021. Oncogene. 40:6153. PubMed Wang Y, et al. 2022. Nat Commun. 13:6663. PubMed Fragoso MF, et al. 2022. Int J Mol Sci. 23:. PubMed Yin S, et al. 2015. Sci Rep. 5: 14432. PubMed Gunda V, et al. 2020. Cancers (Basel). 12:00. PubMed Riebeling T, et al. 2020. Cell Death Differ. . PubMed Peeters R, et al. 2022. Nat Commun. 13:5371. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Tang J, et al. 2021. Front Genet. 12:666451. PubMed Gourvest M, et al. 2021. Leukemia. . PubMed Huang Z, et al. 2021. Am J Cancer Res. 4287:10. PubMed Tan H, et al. 2022. Acta Pharm Sin B. 12:2348. PubMed Seong BKA, et al. 2021. Cancer Cell. 39:1262. PubMed Li K, et al. 2021. J Exp Med. 218:. PubMed Zhan L, et al. 2021. Exp Ther Med. 22:1082. PubMed Hezkiy EE, et al. 2022. Cells. 11:. PubMed Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed Corso J, et al. 2016. Proc Natl Acad Sci U S A. 113: 5688 - 5693. PubMed Lei X, et al. 2022. Nat Commun. 13:3882. PubMed Jin X, et al. 2022. iScience. 25:104349. PubMed |
|---|
| Biology Area | Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Cell Proliferation and Viability, Neuroscience |
|---|
| Gene ID | 308 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Annexin A5 Apoptosis Detection Kit, Dead, Apoptosis |
|---|